Description
Epineuron is developing a novel nerve locator and launching its pivotal trial for nerve regeneration.
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $664,460 at start, $714,460 after amendment #3 (+$50,000).
- #02023-08-01$664,460
- #22024-02-26$714,460+$50,000
- #32024-11-04$714,460
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2023-08-01(start date) | $664,460 | — | Epineuron is developing a novel nerve locator and launching its pivotal trial for nerve regeneration. |
| #2 amendment | 2024-02-26 | $714,460 | +$50,000 | Epineuron is developing a novel nerve locator and launching its pivotal trial for nerve regeneration. |
| #3 amendment | 2024-11-04 | $714,460 | +$0 | Epineuron is developing a novel nerve locator and launching its pivotal trial for nerve regeneration. |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 755782927)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2022-2023-Q4-1002182 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $56,380 | FY2023 |
| 172-2022-2023-Q3-996107 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $28,400 | FY2023 |
| 172-2022-2023-Q3-997457 | National Research Council Canada | Conseil national de recherches Canada · CanExport Innovation | $9,194 | FY2023 |
| 172-2021-2022-Q2-975166 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $250,000 | FY2022 |
| 172-2021-2022-Q1-969501 | National Research Council Canada | Conseil national de recherches Canada · CanExport Innovation | $11,250 | FY2021 |
| 172-2020-2021-Q2-956000 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $185,000 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2023-2024-Q2-1009918 · retrieved 2026-11-16.